Mass conversion from Sandimmun to Sandimmun Neoral: 1 1/2-year experience.
Huraib
S
S
King Fahad National Guard Hospital, Riyadh, Saudi Arabia.
al Khudair
W
W
Selim
H
H
Iqbal
A
A
Quadri
K
K
Abu Romeh
S
S
Chaballout
A
A
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D004304:Dosage Forms; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D012529:Saudi Arabia
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine